Koers Chongqing Zhifei Biological Products Co., Ltd.
Aandelen
300122
CNE100000V20
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
32,8 CNY | -0,09% | -1,18% | -46,33% |
Omzet 2024 * | 58,19 mld. 8,04 mld. 7,41 mld. | Omzet 2025 * | 64,49 mld. 8,91 mld. 8,21 mld. | Marktkapitalisatie | 78,52 mld. 10,84 mld. 10 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 10,4 mld. 1,44 mld. 1,32 mld. | Nettowinst (verlies) 2025 * | 12,57 mld. 1,74 mld. 1,6 mld. | EV/omzet 2024 * | 1,21 x |
Nettoliquiditeiten 2024 * | 7,86 mld. 1,09 mld. 1 mld. | Nettoliquiditeiten 2025 * | 14,74 mld. 2,04 mld. 1,88 mld. | EV/omzet 2025 * | 0,99 x |
K/w-verhouding 2024 * |
7,67
x | K/w-verhouding 2025 * |
6,39
x | Werknemers | 6.545 |
Dividendrendement 2024 * |
2,79% | Dividendrendement 2025 * |
3,04% | Vrij verhandelbaar | 14,73% |
1 dag | -0,09% | ||
1 week | -1,18% | ||
1 maand | -6,55% | ||
3 maanden | -38,14% | ||
6 maanden | -49,00% | ||
Lopend jaar | -46,33% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hai Ping Xu
CHM | Chairman | 43 | 01-01-14 |
Zhen Jing Li
DFI | Director of Finance/CFO | 42 | 01-01-14 |
Ren Sheng Jiang
CHM | Chairman | 71 | 17-08-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ren Sheng Jiang
CHM | Chairman | 71 | 17-08-09 |
Ling Feng Jiang
BRD | Director/Board Member | 44 | 01-08-12 |
Jing Zhang
PRN | Corporate Officer/Principal | 55 | 01-01-07 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
2.58% | 12 M€ | -16,71% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
31-05-24 | 32,8 | -0,09% | 12 763 200 |
30-05-24 | 32,83 | -0,39% | 9 468 116 |
29-05-24 | 32,96 | -0,18% | 9 426 398 |
28-05-24 | 33,02 | -0,36% | 12 138 420 |
27-05-24 | 33,14 | -0,15% | 16 096 680 |
slotkoers Shenzhen S.E., 31 mei 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-46,33% | 10,84 mld. | |
-2,29% | 89,87 mld. | |
-3,95% | 37,57 mld. | |
+63,05% | 26,47 mld. | |
-22,14% | 14,25 mld. | |
-7,96% | 12,99 mld. | |
-9,33% | 11,93 mld. | |
+5,77% | 9,11 mld. | |
-17,66% | 7,32 mld. | |
+88,73% | 7,14 mld. |